Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Cytokine Release Syndrome × Interleukin 1 Receptor Antagonist Protein × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Cytokine Release Syndrome 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1

Interventions

otelixizumab 1 fludarabine phosphate 1 fludarabine 1 Metoprolol 1 Interleukin 1 Receptor Antagonist Protein 1 Infliximab 1 Etanercept 1 Cyclophosphamide 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06703216 2025-06-15

PACER

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1/2 Not yet recruiting

Cytokine Release Syndrome, Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡